- Exchange: SIX Swiss Ex
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Specialty Pharmaceuticals
Basilea Pharmaceutica+ Add to Watchlist
BSLN:SW103.70 CHF 0.10 0.10%
As of 03:02:27 ET on 12/06/2013.
Company Profile for Basilea Pharmaceutica (BSLN)
Basilea Pharmaceutica AG is a biotechnology company conducting research into the development of drugs for the treatment of infectious diseases and dermatological problems. The Company develops anti-bacterial and anti-fungal compounds which destroy infectious organisms.
Key Executives for Basilea Pharmaceutica (BSLN)
|Martin NicklassonChairman||Domenico ScalaVice Chairman|
|Ronald Scott "Ron"Chief Executive Officer||Donato SpotaChief Financial Officer|
|Ingrid Heinze-KraussChief Technology Officer||Achim KaufholdChief Medical Officer|
|Laurenz KellenbergerChief Scientific Officer||Barbara ZinkHead:Corporate Development|